Dorsey & Whitney Trust’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Buy
2,888
+67
+2% +$6.15K 0.01% 612
2025
Q4
$254K Sell
2,821
-7
-0.2% -$664 0.01% 608
2025
Q3
$279K Sell
2,828
-581
-17% -$57.6K 0.01% 558
2025
Q2
$311K Sell
3,409
-844
-20% -$81.6K 0.02% 525
2025
Q1
$481K Sell
4,253
-341
-7% -$36.5K 0.03% 410
2024
Q4
$485K Buy
4,594
+102
+2% +$10.9K 0.03% 398
2024
Q3
$485K Buy
4,492
+135
+3% +$14.7K 0.03% 401
2024
Q2
$473K Sell
4,357
-671
-13% -$79.1K 0.03% 366
2024
Q1
$664K Buy
5,028
+20
+0.4% +$2.5K 0.05% 289
2023
Q4
$609K Buy
5,008
+196
+4% +$21.9K 0.05% 300
2023
Q3
$540K Buy
4,812
+304
+7% +$38.6K 0.05% 301
2023
Q2
$656K Sell
4,508
-410
-8% -$55.7K 0.05% 266
2023
Q1
$635K Sell
4,918
-994
-17% -$125K 0.06% 263
2022
Q4
$757K Sell
5,912
-630
-10% -$73.1K 0.07% 233
2022
Q3
$684K Sell
6,542
-3,186
-33% -$350K 0.07% 235
2022
Q2
$1.02M Sell
9,728
-8,278
-46% -$982K 0.1% 180
2022
Q1
$2.3M Sell
18,006
-16,243
-47% -$1.96M 0.2% 109
2021
Q4
$4.22M Sell
34,249
-2,072
-6% -$271K 0.35% 64
2021
Q3
$5.16M Sell
36,321
-3,887
-10% -$572K 0.48% 53
2021
Q2
$6.28M Sell
40,208
-4,967
-11% -$805K 0.6% 49
2021
Q1
$7.02M Sell
45,175
-3,083
-6% -$478K 0.7% 38
2020
Q4
$7.22M Sell
48,258
-3,088
-6% -$436K 0.84% 31
2020
Q3
$6.79M Sell
51,346
-202
-0.4% -$26.4K 0.9% 32
2020
Q2
$5.97M Buy
51,548
+1,676
+3% +$193K 0.84% 30
2020
Q1
$4.89M Buy
49,872
+200
+0.4% +$26.2K 0.83% 31
2019
Q4
$7.22M Sell
49,672
-922
-2% -$127K 0.96% 25
2019
Q3
$6.74M Buy
50,594
+426
+0.8% +$55K 0.99% 26
2019
Q2
$5.74M Hold
50,168
0.89% 30
2019
Q1
$6.22M Buy
50,168
+740
+1% +$84.1K 0.97% 25
2018
Q4
$4.98M Sell
49,428
-927
-2% -$104K 0.88% 32
2018
Q3
$6.43M Sell
50,355
-396
-0.8% -$47.1K 1% 28
2018
Q2
$5.49M Buy
50,751
+664
+1% +$72.3K 0.95% 34
2018
Q1
$5.3M Sell
50,087
-505
-1% -$58.6K 0.98% 37
2017
Q4
$5.93M Buy
50,592
+461
+0.9% +$52.1K 1.09% 34
2017
Q3
$5.7M Buy
50,131
+1,614
+3% +$186K 1.13% 29
2017
Q2
$6.05M Buy
48,517
+911
+2% +$108K 1.21% 23
2017
Q1
$5.64M Buy
47,606
+3,319
+7% +$376K 1.15% 30
2016
Q4
$4.44M Buy
44,287
+3,411
+8% +$366K 1.01% 34
2016
Q3
$5.16M Sell
40,876
-1,387
-3% -$171K 1.18% 30
2016
Q2
$4.94M Buy
42,263
+1,617
+4% +$183K 1.13% 30
2016
Q1
$4.21M Buy
40,646
+2,287
+6% +$221K 1.05% 30
2015
Q4
$3.82M Buy
38,359
+3,605
+10% +$353K 1.01% 31
2015
Q3
$3.17M Buy
34,754
+139
+0.4% +$13.9K 0.89% 35
2015
Q2
$3.67M Sell
34,615
-742
-2% -$82.1K 0.94% 32
2015
Q1
$4.03M Sell
35,357
-793
-2% -$90.5K 1.02% 30
2014
Q4
$3.98M Sell
36,150
-555
-2% -$58.5K 1.03% 30
2014
Q3
$3.58M Sell
36,705
-4,853
-12% -$477K 0.97% 32
2014
Q2
$4.19M Sell
41,558
-407
-1% -$39.7K 0.91% 30
2014
Q1
$3.85M Sell
41,965
-2,283
-5% -$210K 0.88% 29
2013
Q4
$4M Sell
44,248
-412
-0.9% -$35.7K 1.09% 30
2013
Q3
$3.56M Buy
44,660
+38
+0.1% +$2.99K 1.06% 30
2013
Q2
$3.25M Buy
+44,622
New +$3.34M 1.08% 30

Other funds holding ZBH

Dorsey & Whitney Trust's ZBH Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its Zimmer Biomet (ZBH) stake by 2.4% in Q1 2026, buying an estimated $6.15K and bringing the position to 2,888 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #612.

Dorsey & Whitney Trust first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.22M in Q4 2020. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Dorsey & Whitney Trust held 2,888 shares of Zimmer Biomet worth $261K as of Q1 2026.
  • Dorsey & Whitney Trust bought 67 Zimmer Biomet shares in Q1 2026, an estimated $6.15K.
  • Zimmer Biomet made up 0.01% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #612 holding.
  • Dorsey & Whitney Trust first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Dorsey & Whitney Trust's Zimmer Biomet position peaked at $7.22M in Q4 2020.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.